Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy

Autor: Sonpavde, G. *, Periman, P.O., Bernold, D., Weckstein, D., Fleming, M.T., Galsky, M.D., Berry, W.R., Zhan, F., Boehm, K.A., Asmar, L., Hutson, T.E.
Zdroj: In Annals of Oncology February 2010 21(2):319-324
Databáze: ScienceDirect